rs141576468
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5
The NM_145207.3(AFG2A):c.2081G>A(p.Gly694Glu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000192 in 1,611,318 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_145207.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AFG2A | NM_145207.3 | c.2081G>A | p.Gly694Glu | missense_variant, splice_region_variant | 12/16 | ENST00000274008.5 | NP_660208.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPATA5 | ENST00000274008.5 | c.2081G>A | p.Gly694Glu | missense_variant, splice_region_variant | 12/16 | 1 | NM_145207.3 | ENSP00000274008.3 | ||
SPATA5 | ENST00000422835.2 | n.2123G>A | splice_region_variant, non_coding_transcript_exon_variant | 12/15 | 1 | |||||
SPATA5 | ENST00000675612.1 | c.2150G>A | p.Gly717Glu | missense_variant, splice_region_variant | 13/17 | ENSP00000502453.1 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152062Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000104 AC: 26AN: 249194Hom.: 0 AF XY: 0.0000966 AC XY: 13AN XY: 134638
GnomAD4 exome AF: 0.000199 AC: 291AN: 1459256Hom.: 0 Cov.: 30 AF XY: 0.000189 AC XY: 137AN XY: 725868
GnomAD4 genome AF: 0.000118 AC: 18AN: 152062Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74272
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 19, 2024 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 28293831, 27683084, 30577886) - |
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | AFG2A: PM1, PM2, PM3, PP3 - |
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 27, 2022 | This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 694 of the SPATA5 protein (p.Gly694Glu). This variant is present in population databases (rs141576468, gnomAD 0.02%). This missense change has been observed in individual(s) with global developmental delay, infantile spasms, profound dystonia, and sensorineural hearing loss (PMID: 27683084). ClinVar contains an entry for this variant (Variation ID: 449961). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at